| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 49.26B | 48.73B | 43.23B | 44.01B | 47.00B | 42.23B |
| Gross Profit | 16.09B | 15.60B | 12.20B | 12.61B | 14.14B | 13.12B |
| EBITDA | 5.55B | 5.47B | 3.88B | 3.29B | 4.81B | 5.42B |
| Net Income | 2.08B | 2.21B | 999.00M | 332.00M | 1.93B | 2.41B |
Balance Sheet | ||||||
| Total Assets | 62.76B | 63.36B | 61.02B | 61.84B | 65.04B | 63.91B |
| Cash, Cash Equivalents and Short-Term Investments | 14.00B | 14.54B | 13.44B | 10.91B | 11.38B | 12.98B |
| Total Debt | 9.98B | 9.90B | 11.49B | 11.86B | 14.44B | 18.71B |
| Total Liabilities | 25.60B | 25.45B | 26.39B | 28.75B | 32.99B | 35.40B |
| Stockholders Equity | 34.93B | 35.72B | 32.63B | 31.23B | 30.32B | 26.95B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.11B | 2.43B | 1.46B | 1.76B | 1.14B |
| Operating Cash Flow | 0.00 | 4.11B | 5.37B | 3.61B | 4.30B | 3.79B |
| Investing Cash Flow | 0.00 | -1.21B | -2.44B | -2.15B | -2.36B | -1.05B |
| Financing Cash Flow | 0.00 | -2.54B | -1.26B | -3.21B | -4.21B | 1.03B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥26.28B | 6.46 | ― | 3.21% | 9.61% | 173.72% | |
75 Outperform | ¥53.51B | 50.64 | 9.07% | 4.46% | -1.14% | 34.15% | |
73 Outperform | ¥57.10B | 8.68 | ― | 4.32% | -31.99% | -44.75% | |
67 Neutral | ¥818.07B | 77.75 | -2.50% | 3.49% | -6.83% | -123.67% | |
65 Neutral | ¥281.84B | 11.03 | 9.45% | 2.65% | -0.04% | 3.15% | |
63 Neutral | ¥217.57B | 10.31 | 6.95% | 3.06% | -7.36% | -574.56% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |